Siemens Biomarker Multi-modality

Purpose of this Study

As part of the study, you'll get your regular CT scan, plus a few extra pictures just for the study. You'll also get an MRI, either on the same day or another day—whichever works best for you. On the same day as your MRI, you’ll also get an ultrasound. If you haven’t had a certain blood test called a hematocrit test in the last day, you’ll get a small blood test during your CT scan to check how healthy your liver is.

Who Can Participate?

Eligibility

Who can join the study: - Adults - Must be scheduled for a CT scan that includes the liver - Must be able to understand and agree to join the study Who cannot join the study: - People who can’t safely have the scans needed - People with a BMI (body mass index) over 45, because the MRI machine might not work for them

Age Range

18-110

Sex/Genders

Male (cisgender)
Female (cisgender)
Non-binary or gender fluid
Transgender male
Transgender female
Looking for Healthy Participants
No

What is Involved?

Description

This study wants to see how well two tests—called PCCT and ultrasound—can find fat and scars in the liver. To check if they work, doctors will compare them to another test called an MRI, which is known to be very good.

Locations

Duke University Hospital

Compensation

Yes

Spanish Materials Available

No

Study Details

Full Title

Siemens Biomarker Multi-modality

Principal Investigator

Mustafa
Bashir

Protocol Number

PRO00118520

Phase

N/A

Enrollment Status

Pending Open to Enrollment